MLLT3 and acute myeloid leukemia: The DEG signatures of iKMT2A-MLLT3 AML cells derived from TPO-exposed HSC (bulk and GFP+ fraction) were characterized by higher expression of multiple genes downstream of the TPO receptor MPL.